We report here that depending on the disease, single or dual blockade of IL34 and CSF1 is needed for controlling inflammation consistent with the concordant tissue-specific expression of both cytokines in diseases such as colitis or arthritis. The gene discussed is CSF1; the disease is arthritic joint disease.